These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 24363202

  • 1. Quantitative proteomic dissection of a native 14-3-3ε interacting protein complex associated with hepatocellular carcinoma.
    Bai C, Tang S, Bai C, Chen X.
    Amino Acids; 2014 Apr; 46(4):841-52. PubMed ID: 24363202
    [Abstract] [Full Text] [Related]

  • 2. 14-3-3ε mediates the cell fate decision-making pathways in response of hepatocellular carcinoma to Bleomycin-induced DNA damage.
    Tang S, Bao H, Zhang Y, Yao J, Yang P, Chen X.
    PLoS One; 2013 Apr; 8(3):e55268. PubMed ID: 23472066
    [Abstract] [Full Text] [Related]

  • 3. Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
    Liu TA, Jan YJ, Ko BS, Wu YJ, Lu YJ, Liang SM, Liu CC, Chen SC, Wang J, Shyue SK, Liou JY.
    Oncotarget; 2015 Nov 17; 6(36):38967-82. PubMed ID: 26516929
    [Abstract] [Full Text] [Related]

  • 4. 14-3-3ε boosts bleomycin-induced DNA damage response by inhibiting the drug-resistant activity of MVP.
    Tang S, Bai C, Yang P, Chen X.
    J Proteome Res; 2013 Jun 07; 12(6):2511-24. PubMed ID: 23590642
    [Abstract] [Full Text] [Related]

  • 5. Upregulation of focal adhesion kinase by 14-3-3ε via NFκB activation in hepatocellular carcinoma.
    Ko BS, Jan YJ, Chang TC, Liang SM, Chen SC, Liu TA, Wu YM, Wang J, Liou JY.
    Anticancer Agents Med Chem; 2013 May 07; 13(4):555-62. PubMed ID: 22934705
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma.
    Ko BS, Chang TC, Hsu C, Chen YC, Shen TL, Chen SC, Wang J, Wu KK, Jan YJ, Liou JY.
    Histopathology; 2011 Apr 07; 58(5):705-11. PubMed ID: 21401702
    [Abstract] [Full Text] [Related]

  • 7. Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma.
    Yang X, Zou P, Yao J, Yun D, Bao H, Du R, Long J, Chen X.
    J Proteome Res; 2010 Mar 05; 9(3):1402-15. PubMed ID: 20000738
    [Abstract] [Full Text] [Related]

  • 8. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Yu CY, Lu FJ, Chow LP.
    J Proteome Res; 2005 Mar 05; 4(6):2062-9. PubMed ID: 16335951
    [Abstract] [Full Text] [Related]

  • 9. Prognostic Significance of 14-3-3ε, Aldo-keto Reductase Family 1 B10 and Metallothionein-1 in Hepatocellular Carcinoma.
    Wu CY, Jan YJ, Ko BS, Wu YJ, Wu YJ, Liou JY.
    Anticancer Res; 2018 Dec 05; 38(12):6855-6863. PubMed ID: 30504401
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma.
    Li C, Ruan HQ, Liu YS, Xu MJ, Dai J, Sheng QH, Tan YX, Yao ZZ, Wang HY, Wu JR, Zeng R.
    J Proteome Res; 2012 Feb 03; 11(2):871-85. PubMed ID: 22082227
    [Abstract] [Full Text] [Related]

  • 12. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.
    Kang YH, Ji NY, Lee CI, Lee HG, Kim JW, Yeom YI, Kim DG, Yoon SK, Kim JW, Park PJ, Song EY.
    Amino Acids; 2011 Mar 03; 40(3):1003-13. PubMed ID: 20821239
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis induced by 1,3,6,7-tetrahydroxyxanthone in Hepatocellular carcinoma and proteomic analysis.
    Fu WM, Zhang JF, Wang H, Tan HS, Wang WM, Chen SC, Zhu X, Chan TM, Tse CM, Leung KS, Lu G, Xu HX, Kung HF.
    Apoptosis; 2012 Aug 03; 17(8):842-51. PubMed ID: 22610480
    [Abstract] [Full Text] [Related]

  • 14. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis.
    Yu Y, Shen H, Yu H, Zhong F, Zhang Y, Zhang C, Zhao J, Li H, Chen J, Liu Y, Yang P.
    Mol Biosyst; 2011 Jun 03; 7(6):1908-16. PubMed ID: 21468425
    [Abstract] [Full Text] [Related]

  • 15. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
    Wang XQ, Zhu YQ, Lui KS, Cai Q, Lu P, Poon RT.
    Clin Cancer Res; 2008 Nov 01; 14(21):6813-20. PubMed ID: 18980975
    [Abstract] [Full Text] [Related]

  • 16. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
    Sun Y, Mi W, Cai J, Ying W, Liu F, Lu H, Qiao Y, Jia W, Bi X, Lu N, Liu S, Qian X, Zhao X.
    J Proteome Res; 2008 Sep 01; 7(9):3847-59. PubMed ID: 18646787
    [Abstract] [Full Text] [Related]

  • 17. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R, An H, Yu Y, Zhang M, Liu S, Xu H, Guo Z, Cheng T, Cao X.
    Cancer Res; 2003 Dec 01; 63(23):8323-9. PubMed ID: 14678992
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
    Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang Y, Tang GN, Zhou WP, Sun SH.
    Hepatology; 2013 May 01; 57(5):1882-92. PubMed ID: 23239537
    [Abstract] [Full Text] [Related]

  • 19. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M, Ladu S, Calvisi DF, Simile MM, Bonelli P, Daino L, Tomasi ML, Seddaiu MA, Feo F, Pascale RM.
    J Hepatol; 2011 Jul 01; 55(1):111-9. PubMed ID: 21419759
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
    Urbanik T, Köhler BC, Boger RJ, Wörns MA, Heeger S, Otto G, Hövelmeyer N, Galle PR, Schuchmann M, Waisman A, Schulze-Bergkamen H.
    Int J Oncol; 2011 Jan 01; 38(1):121-31. PubMed ID: 21109933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.